Communication for the Heartland Regional Genetics Group


Options: Use Classic View

Use Proportional Font
Show HTML Part by Default
Show All Mail Headers

Topic: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
"Dean, Lori" <[log in to unmask]>
Tue, 4 Jun 2013 16:52:13 +0000
text/plain (7 kB) , text/html (13 kB)

Lori Williamson Dean, MS, CGC, LGC
Department Chair and Assistant Professor, Department of Genetic Counseling
Program Manager, Heartland Genetics & NBS Collaborative
University of Arkansas for the Medical Sciences

Phone: 405-819-2135 or 501-526-7703


Confidentiality Notice: This e-mail message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information.  Any unauthorized review, use, disclosure or distribution is prohibited.  If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message.

From: Sophie Stich [mailto:[log in to unmask]]
Sent: Tuesday, June 04, 2013 8:54 AM
To: Amy Brower; Barb Jackson; Barry Thompson; Bonnie Frederick; Schaefer, Bradley; Camille Miller; Celia Kaye, MD, PhD; Debbie Maiese; Deborah Stevens; Donna Williams; Foster, Dustin M; Gina Gembel; Greer Stephens; Hans Andersson; James O'Leary; Janice Bach; Jill Shuger; Joann Bodurtha; Jodi Griffin; John Moeschler, MD, MS; Joyce Hooker; Judith Benkendorf; Karen Smith; Kathryn Hassell, MD; Kathy Harris, MBA; Klaas Wierenga; Kunal Sanghavi; Lianne Hasegawa; Libby DeLeon; Lisa Gorman; Liza Creel; Lokie Harmond; Dean, Lori; Marci Sontag; Mary Rose Simpson; Meredith Weaver; Michele Caggana, ScD, FACMG; Monica McClain, PhD; Peter Antal; Phaidra Browning; Rani Singh, PhD, RD, LD; Sally Hiner; Sharon Romelczyk; Shona Whitehead; Sikha Singh; Sue2 Ginsburg; Sylvia Au
Cc: Michael Watson; Alisha Keehn
Subject: Please Join ACMG for a Two-Part Webinar Series on the Current Crisis in Molecular Pathology Reimbursement

Dear RC Project Directors and Project Managers,

Please join ACMG for a two-part webinar series on the current crisis in molecular pathology reimbursement, and what labs can be doing now to optimize the chances of a favorable outcome.

Background & Objectives

ACMG is providing this webinar series as an educational resource to provide laboratories with information and resources they need to participate effectively in the ongoing molecular pathology rate-setting process. Payers such as Medicare will drastically slash reimbursements for the new molecular pathology (MoPath) codes moving forward, UNLESS laboratories take action now.

Presented by speakers from Quorum Consulting, Inc<https://urldefense.proofpoint.com/v1/url?u=http://acmg.informz.net/z/cjUucD9taT0zMjYwNDg2JnA9MSZ1PTEwMDU5ODkzNDUmbGk9MTcyNzY0Mzg/index.html&k=7DHVT22D9IhC0F3WohFMBA%3D%3D%0A&r=rX%2BpwtxS62RFz%2BMe%2BGygIuxlYqsdJqSFMkXPQTg4Occ%3D%0A&m=6N55CscmrooxS4YIPaFQykFN9yvBJ0YmC%2FG1E1dakU4%3D%0A&s=8c81102858102064067bc5996fb7a730d881788cb6048d09da654e4fb01a09c0>., Part I addresses the background and current status of the rate-setting process, while Part II focuses on what laboratories can and should be doing to advocate for sustainable reimbursement during this critical period.*

Registration is limited for this webinar series so it is offered on a first come first serve basis.  Please register soon if you are interested in participating

Who Should Attend

Laboratory Directors, Chief Financial Officers, Billing Managers, and/or any individuals in your organization who supervise billing and reimbursement.

If this does not describe you, please forward this on to the appropriate individuals as soon as possible.

Part I

Molecular Pathology Reimbursement: Current State of Play

Date: Monday, June 10, 2013

Time: 12:00-1:00pm EDT/9:00-10:00am PDT

Part II

Molecular Pathology Reimbursement: Taking Action in a Time of Crisis

Date: Tuesday, June 11, 2013

Time: 12:00-1:00pm EDT/9:00-10:00am PDT

Register for both sessions here: https://urldefense.proofpoint.com/v1/url?u=https://www2.gotomeeting.com/register/125056578&k=7DHVT22D9IhC0F3WohFMBA%3D%3D%0A&r=rX%2BpwtxS62RFz%2BMe%2BGygIuxlYqsdJqSFMkXPQTg4Occ%3D%0A&m=6N55CscmrooxS4YIPaFQykFN9yvBJ0YmC%2FG1E1dakU4%3D%0A&s=992e9c89046ad86230a52dd2b5020a2168f81a5279abf1e7c2d32d1ad1ec84b0<https://urldefense.proofpoint.com/v1/url?u=http://acmg.informz.net/z/cjUucD9taT0zMjYwNDg2JnA9MSZ1PTEwMDU5ODkzNDUmbGk9MTcyNzY0Mzk/index.html%253Chttps://www2.gotomeeting.com/register/125056578%253Chttp:/acmg.informz.net/z/cjUucD9taT0zMjYwNDg2JnA9MSZ1PTEwMDU5ODkzNDUmbGk9MTcyNzY0Mzk/index.html&k=7DHVT22D9IhC0F3WohFMBA%3D%3D%0A&r=rX%2BpwtxS62RFz%2BMe%2BGygIuxlYqsdJqSFMkXPQTg4Occ%3D%0A&m=6N55CscmrooxS4YIPaFQykFN9yvBJ0YmC%2FG1E1dakU4%3D%0A&s=872ed7e06dda853952858acda7153b5684d0964b75969dde8c6ea1b0e9ce04d8>>

Labs such as yours hold the key to influencing the outcome of the rate-setting process. Learn about how you can take action now to support the fight for sustainable molecular diagnostic reimbursement in 2013 and beyond.

*This webinar is intended strictly as an educational resource for clinical laboratory geneticists to help them understand and advocate for reasonable levels of reimbursement for molecular genetics laboratory services.  ACMG does not warrant the accuracy, completeness, or timeliness of the information presented  The information presented should not be considered inclusive of all applicable legal and regulatory requirements, and adherence to any information or suggestions contained in the presentation  does not assure compliance with such legal and regulatory requirements. Applicable federal and state laws vary, and specific questions should be referred to a legal professional familiar with such law. The materials presented are current as of June 3, 2013.

NCC Staff

Sophia Stich
Project Coordinator, NCC
American College of Medical Genetics and Genomics
7220 Wisconsin Avenue, Suite 300
Bethesda, MD 20814
[log in to unmask]<mailto:[log in to unmask]>
T: 301-718-9603
F: 301-718-9604

Confidentiality Notice: This e-mail message, including any attachments,
is for the sole use of the intended recipient(s) and may contain
confidential and privileged information.  Any unauthorized review,
use, disclosure or distribution is prohibited.  If you are not the 
intended recipient, please contact the sender by reply
e-mail and destroy all copies of the original message.